Expression of lipoxygenase in human bladder carcinoma and growth inhibition by its inhibitors

Journal of Urology

Volumn 170, Issue 5, 2003, Pages 1994-1999

  Yoshimura, Rikio ^a,d   Matsuyama, Masahide ^a   Tsuchida, Kenji ^a   Kawahito, Yutaka ^b   Sano, Hajime ^c   Nakatani, Tatsuya ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d OSAKA CITY UNIVERSITY HOSPITAL   (Japan)

Author keywords

Apoptosis; Arachidonate 12 lipoxygenase; Arachidonate 5 lipoxygenase; Bladder; Bladder neoplasms

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; BAICALEIN; CAFFEIC ACID; DNA; HOE 33342; LIPOXYGENASE INHIBITOR; MESSENGER RNA; NORDIHYDROGUAIARETIC ACID;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BLADDER CARCINOMA; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CHROMATIN CONDENSATION; CONTROLLED STUDY; CYSTITIS; CYTOPLASM; ENZYME INDUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TRANSITIONAL CELL CARCINOMA;

EID: 0141988847     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000080296.54262.c8     Document Type: Article

References (20)

1. Yoshimura, R., Sano, H., Masuda, C., Kawamura, M., Tsubouchi, Y., Chargui, J. et al: Expression of cyclooxygenase-2 in prostate carcinoma. Cancer, 89: 589, 2000
2. Funk, C. D.: The molecular biology of mammalian lipoxygenases and the quest for eicosanoid functions using lipoxygenase-deficient mice. Biochim Biophys Acta, 1304: 65, 1996
3. Brash, A. R.: Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate. J Biol Chem, 274: 23679, 1999
4. Timar, J., Raso, E., Dome, B., Li, L., Grignon, D., Nie, D. et al: Expression, subcellular localization and putative function of platelet-type 12-lipoxygenase in human prostate cancer cell lines of different metastatic potential. Int J Cancer, 87: 37, 2000
5. Nie, D., Hillman, G. G., Geddes, T., Tang, K., Pierson, C., Grignon, D. J. et al: Platelet-type 12-lipoxygenase in a human prostate carcinoma stimulates angiogenesis and tumor growth. Cancer Res, 58: 4047, 1998
6. Timar, J., Chen, Y. Q., Liu, B., Bazaz, R., Taylor, J. D. and Honn, K. V.: The lipoxygenase metabolite 12 (S)-HETE promotes alpha IIb beta 3 integrin-mediated tumor-cell spreading on fibronectin. Int J Cancer, 52: 594, 1992
7. Steele, V. E., Holmes, C. A., Hawk, E. T., Kopelovich, L., Lubet, R. A., Crowell, J. A. et al: Lipoxygenase inhibitors as potential cancer chemopreventives. Cancer Epidemiol Biomarkers Prev, 8: 467, 1999
8. Fitzgerald, S. M. and Flinn, S.: Evaluating research studies using the analysis of variance (ANOVA): issues and interpretations. J Hand Ther, 13: 56, 2000
9. Yoshimura, R., Matsuyama, M., Segawa, Y., Hase, T., Mitsuhashi, M., Tsuchida, K. et al: Expression of peroxisome proliferator-activated receptors (PPARs) in human urinary bladder carcinoma and growth inhibition by its agonists. Int J Cancer, 104: 597, 2003
10. Needleman, P., Turk, J., Jakschik, B. A., Morrison, A. R. and Lefkowith, J. B.: Arachidonic acid metabolism. Annu Rev Biochem, 55: 69, 1986
11. Tsukada, T., Nakashima, K. and Shirakawa, S.: Arachidonate 5-lipoxygenase inhibitors show potent antiproliferative effects of human leukemia cell lines. Biochem Biophys Res Commun, 140: 832, 1986
12. Avis, I. M., Jett, M., Boyle, T., Vos, M. D., Moody, T., Treston, A. M. et al: Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling. J Clin Invest, 97: 806, 1996
13. Natarajan, R., Esworthy, R., Bai, W., Gu, J. L., Wilczynski, S. and Nadler, J.: Increase 12-lipoxygenase expression in breast cancer tissues and cells. Regulation by epidermal growth factor. J Clin Endocrinol Metab, 82: 1790, 1997
14. Kamitani, H., Geller, M. and Eling, T.: The possible involvement of 15-lipoxygenase/leukocyte type 12-lipoxygenase in colorectal carcinogenesis. Adv Exp Med Biol, 469: 593, 1999
15. Timar, J., Raso, E., Honn, K. V. and Hagmann, W.: 12-Lipoxgenase expression in human melanoma cell lines. Adv Exp Med Biol, 469: 617, 1999
16. Ding, X. Z., Iversen, P., Cluck, M. W., Knezetic, J. A. and Adrian, T. E.: Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells. Biochem Biophys Res Commun, 261: 218, 1999
17. Timar, J., Silletti, S., Bazaz, R., Raz, A. and Honn, K. V.: Regulation of melanoma-cell motility by the lipoxygenase metabolite 12-(S)-HETE. Int J Cancer, 55: 1003, 1993
18. Honn, K. V., Timar, J., Rozhin, J., Bazaz, R., Sameni, M., Ziegler, G. et al: A lipoxygenase metabolite, 12-(S)-HETE, stimulates protein kinase C-mediated release of cathepsin B from malignant cells. Exp Cell Res, 214: 120, 1994
19. Nie, D., Tang, K., Diglio, C. and Honn, K. V.: Eicosanoid regulation of angiogenesis: role of endothelial arachidonate 12-lipoxygenase. Blood, 95: 2304, 2000
20. Chopra, H., Timar, J., Chen, Y. Q., Rong, X. H., Grossi, I. M., Fitzgerald, L. A. et al: The lipoxygenase metabolite 12 (S)-HETE induces a cytoskeleton-dependent increase in surface expression of integrin alpha IIb beta 3 on melanoma cells. Int J Cancer, 49: 774, 1991